Publications by authors named "Angela van Tilborg"

27Publications

Polymorphisms in MMP-14 and MMP-2 genes and ovarian cancer survival.

Cancer Biomark 2019 ;25(3):233-241

Department of Obstetrics and Gynaecology, Radboud University Nijmegen Medical Centre, 6500 HB Nijmegen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/CBM-181826DOI Listing
January 2020

Prognostic significance of highly sulfated chondroitin sulfates in ovarian cancer defined by the single chain antibody GD3A11.

Gynecol Oncol 2016 Mar 28;140(3):527-36. Epub 2015 Dec 28.

Department of Obstetrics and Gynaecology, Radboud University Medical Center, PO Box 9101, 6500 HB Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.12.024DOI Listing
March 2016

Mutational profiling of kinases in glioblastoma.

BMC Cancer 2014 Sep 26;14:718. Epub 2014 Sep 26.

Department of Oncology, University of Torino, SP 142, Km 3,95, Candiolo, Torino, 10060, Italy; Candiolo Cancer Institute - FPO, IRCCS, Candiolo, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-14-718DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192443PMC
September 2014

Sulfated sugars in the extracellular matrix orchestrate ovarian cancer development: 'when sweet turns sour'.

Gynecol Oncol 2014 Nov 23;135(2):371-81. Epub 2014 Aug 23.

Department of Biochemistry, Radboud Institute for Molecular Life Sciences, PO Box 9101, 6500 HB Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.08.023DOI Listing
November 2014

Novel single-chain antibody GD3A10 defines a chondroitin sulfate biomarker for ovarian cancer.

Biomark Med 2014 ;8(5):699-711

Department of Biochemistry, Nijmegen Center for Molecular Life Sciences, PO Box 9101, 6500 HB Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/bmm.14.6DOI Listing
August 2015

The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone.

Neuro Oncol 2014 Sep 6;16(9):1263-73. Epub 2014 Feb 6.

Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands (R.J.M., C.J.F.v.N.); Neurosurgical Center Amsterdam, Academic Medical Center, Amsterdam, The Netherlands (F.E.B., D.V., W.P.V.); Laboratory of Molecular Genetics, The Oncogenomics Center, Institute for Cancer Research and Treatment, University of Torino Medical School, Candiolo, Italy (S.La., C.Z., A.B., F.E.B.); Department of Pathology, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands (J.W.M.J., S.H.E.B.-S., P.W.); Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands (P.W.); Department of Neurogenetics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands (T.J.M.H.); Department of Neuropathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands (D.T., A.A.v.T.); Neurosurgical Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands (W.P.V.); Department of Neurosurgery, St. Elisabeth Hospital Tilburg, The Netherlands (S.Le.); Department of Neurosurgery, Erasmus Medical Center, Rotterdam, The Netherlands (S.Le.); FIRC Institute of Molecular Oncology, Milan, Italy (A.B.)Present affiliation: Department of Clinical Genetics, Academic Medical Center and University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands (F.E.B.); Department of Pathology, Radboud University Medical Center Nijmegen, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, The Netherlands (A.A.v.T.); Department of Neurology, Radboud University Medical Centre Nijmegen, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, The Netherlands (S.H.E.B.-S.); Department of Pathology, Stichting PAMM, Michelangelolaan 2, 5623 EJ Eindhoven, The Netherlands (J.W.M.J.).

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/nou005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136888PMC
September 2014

Müllerian precursor lesions in serous ovarian cancer patients: using the SEE-Fim and SEE-End protocol.

Mod Pathol 2014 Jul 6;27(7):1002-13. Epub 2013 Dec 6.

Department of Obstetrics and Gynecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2013.212DOI Listing
July 2014

Histopathologic assessment of the entire endometrium in asymptomatic women.

Hum Pathol 2013 Oct 9;44(10):2293-301. Epub 2013 Aug 9.

Department of Obstetrics & Gynecology (791), Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB, Nijmegen, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2013.05.011DOI Listing
October 2013

DNA methylation-based biomarkers in bladder cancer.

Nat Rev Urol 2013 Jun 30;10(6):327-35. Epub 2013 Apr 30.

Department of Pathology, Erasmus MC, P. O. Box 2040, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2013.89DOI Listing
June 2013

Bladder cancer: novel molecular characteristics, diagnostic, and therapeutic implications.

Urol Oncol 2010 Jan-Feb;28(1):91-6

Department of Pathology, Josephine Nefkens Institute, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10781439090018
Publisher Site
http://dx.doi.org/10.1016/j.urolonc.2009.06.007DOI Listing
May 2010

Absence of AKT1 mutations in glioblastoma.

PLoS One 2009 May 20;4(5):e5638. Epub 2009 May 20.

Neurosurgical Center Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005638PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680963PMC
May 2009

Bladder cancer biomarkers and their role in surveillance and screening.

Int J Urol 2009 Jan;16(1):23-30

Department of Pathology, Josephine Nefkens Institute, Erasmus MC, CA, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1442-2042.2008.02174.xDOI Listing
January 2009

Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma.

Cancer Res 2007 Apr;67(8):3545-50

Laboratory of Molecular Genetics, The Oncogenomics Center, Institute for Cancer Research and Treatment, University of Torino Medical School, Candiolo (TO) 10060, Italy.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-54
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-07-0065DOI Listing
April 2007

Lack of genetic and epigenetic changes in meningiomas without NF2 loss.

J Pathol 2006 Mar;208(4):564-73

Department of Pathology, Josephine Nefkens Institute, Erasmus MC, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.1909DOI Listing
March 2006

Chromosomal instability in meningiomas.

J Neuropathol Exp Neurol 2005 Apr;64(4):312-22

Department of Pathology, Erasmus MC, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnen/64.4.312DOI Listing
April 2005

The random development of LOH on chromosome 9q in superficial bladder cancers.

J Pathol 2002 Nov;198(3):352-8

Department of Pathology, Josephine Nefkens Institute, Erasmus University Rotterdam, PO Box 1738, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.1215DOI Listing
November 2002